SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Lindsten H.) "

Sökning: WFRF:(Lindsten H.)

  • Resultat 1-3 av 3
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Cheng, Q., et al. (författare)
  • Clinical epidemiology of Guillain-Barré syndrome in adults in Sweden 1996-97 : A prospective study
  • 2000
  • Ingår i: European Journal of Neurology. - : Wiley. - 1351-5101 .- 1468-1331. ; 7:6, s. 685-692
  • Tidskriftsartikel (refereegranskat)abstract
    • We described clinical manifestations, outcomes, prognostic indicators and clinico-epidemiological subgroups for 53 adult patients with Guillain-Barré syndrome (GBS) in Sweden during the period 1996-97. These patients were identified from a population of 2.8 million inhabitants and prospectively followed up for one year by a network of neurologists. An additional 10 cases, of whom five were adults who had not been prospectively followed up, were not included in the analyses. At 6 months after onset 80% of the patients could walk without aid, while at 1 year 46% were fully recovered, 42% had mild residual signs or symptoms, 4% had moderate and 6% severe disabilities, and 2% had died. Intravenous human immunoglobulin or plasmapheresis were used in 72% of the patients. The sum of the Medical Research Council (MRC) score at nadir was found as the only significant predictor for residual signs at 1 year in a multivariate model. Three subgroups, with different clinico-epidemiological characteristics, were identified by using cluster analysis. In conclusion, GBS in Sweden is frequently preceded by a respiratory infection, is often treated with immunomodulatory therapies, and exhibits a high recovery rate and a low fatality rate.
  •  
2.
  • Lindsten, K, et al. (författare)
  • GFP reporter mouse models of UPS proteolytic function
  • 2006
  • Ingår i: FASEB journal : official publication of the Federation of American Societies for Experimental Biology. - : Wiley. - 1530-6860. ; 20:7, s. 1027-author
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
  •  
3.
  • Sanga, M., et al. (författare)
  • A panel of PCR-inhibitory reference materials for quality evaluation of multiplex STR analysis kits : -
  • 2015
  • Ingår i: Abstracts ISFG. ; , s. 226-
  • Konferensbidrag (refereegranskat)abstract
    • PCR inhibition is a key challenge in forensic DNA analysis. Substances interfering with the amplification of PCR products can lower the success rate of Short Tandem Repeat (STR) analysis or generate ambiguous DNA profiles.For forensic DNA laboratories it is therefore vital to have knowledge about how common inhibitory substances affect their STR analysis system. We have developed a broad-range panel of standardized PCR-inhibitory reference materials (RMs), representing the heterogeneous stains found at crime scenes. The panel, including solutions prepared from for example cigarette paper,chewing gum, moist snuff and humic acid, is a tool for quality evaluation of STR systems. We applied the RMs to challenge PowerPlex® ESX 16 Fast System (ESX Fast). Although ESX Fast tolerated high levels of some inhibitors, several RMs caused problems in different ways. Humic acid had a specific negative effect on amelogenin amplification, moist snuff hindered amplification of longer fragments, and chewing gum caused generally lowered allele peak heights. These different effects may provide information regarding the mechanisms of inhibition. For instance, our results indicate that one effect of humic acid on ESX Fast analysis is chelation of Mg2+ ions, thus altering the melting temperatures of the primers. In the developmental validation of STR systems, a limited evaluation of PCR inhibition involving only a few substances is generally performed. Applying a broad panel of RMs will ensure that a wider range of inhibitory substances from crime scene samples are included, giving a better understanding of inhibitor tolerance and effects. 
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-3 av 3

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy